SecBot SecBot
8-K ·Filed May 22, 2026
TN

TNONW

Tenon Medical, Inc.
BEARISH
Impact 7/10
Horizonweeks Processed5mo ago SEC0001213900-26-060662
8-K context-dependent: Items 3.01
Actionable Insight ▼ Bearish

Monitor for the company's compliance plan submission by July 6, 2026. A credible plan involving a capital raise or reverse split could mitigate delisting risk. Failure to submit or an unacceptable plan increases delisting probability, which would likely render the warrants (TNONW) nearly worthless.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
TNONW ▲ +103.70% at T+60d
SHORT call ✗ call lost -103.70% · α vs SPY -100.98% · entry $0.0108 → $0.0220
Entry = T+0 close
May 22, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.01%
$0.0108
settled 5mo ago
T+5d
0.00%
call 0.00% · α +1.21%
$0.0108
settled 5mo ago
T+20d
-45.37%
call +45.37% · α +43.42%
$0.005900
settled 4mo ago
T+60d
+103.70%
call -103.70% · α -100.98%
$0.0220
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Tenon Medical received a Nasdaq delisting notice for failing to meet the minimum $2.5M stockholders' equity requirement (reported equity of $1.895M as of March 31, 2026). The company has until July 6, 2026 to submit a compliance plan, with a possible 180-day extension. Failure to regain compliance could result in delisting of its common stock and warrants, severely impacting liquidity and warrant value.

Key Facts

  • Nasdaq notified Tenon Medical on May 21, 2026 of non-compliance with Listing Rule 5550(b)(1) for minimum stockholders' equity of $2.5M.
  • As of March 31, 2026, the company reported stockholders' equity of $1.895M, below the requirement.
  • Company has 45 calendar days (until July 6, 2026) to submit a plan to regain compliance.
  • If plan is accepted, Nasdaq may grant up to 180 additional calendar days to regain compliance.
  • Company does not currently meet alternative compliance standards (market value of listed securities or net income from continuing operations).
  • The notice has no immediate effect on trading, but potential delisting would severely reduce liquidity and institutional ownership.

Financial Impact

Stockholders' equity deficiency of $605,000 below the $2.5M minimum

stockholders_equity

Risk Factors

  • Company may fail to submit an acceptable compliance plan by the deadline.
  • Even if a plan is accepted, the company may not regain compliance within the extended period.
  • Delisting would force trading to OTC markets, severely reducing liquidity and institutional interest.
  • Warrants (TNONW) could become worthless if common stock is delisted.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-060662
Document: 0001213900-26-060662-index-headers.html0001213900-26-060662
Document: 0001213900-26-060662-index.html0001213900-26-060662
Document: 0001213900-26-060662.txt0001213900-26-060662

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026